Jesus (host)
speaker
183 appearances
2 recordings
1 series
first heard Jul 2026
last heard 7 Aug
Jesus (host)’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Aug 2026 with 1.
Appearances
Mm-hmm.
Excellent.
That's so good to hear that all those aspects were an add plus to the
Yeah, to the development of the trial.
And in that same line, every time a team, you know, executes a first in human, they learn things they couldn't have any other way.
So what are some of those lessons that you're going to carry forward with you, both the ones that validated your approach and are there any that are making you rethink the strategy moving forward?
Excellent.
And to close, I would like to transition a little bit to the Agsoft focus and what's next for the company.
So please feel free to share as much or as little as you're comfortable with when speaking to how has the Panama experience shaped where Agsoft is headed next?
what does the road ahead look like for where you're sitting right now, having had this experience?
That sounds very exciting.
Matt, in closing, and for the innovators in our audience who are in their early stage of deciding where to conduct their first in-human clinical trial,
as a milestone and wondering whether Latin America belongs in that conversation.
What are the single most important things that you would want them to take from your experience?
Matt, this has been a genuinely compelling conversation.
Thank you so much for sharing with us and our audience your experience in conducting this trial.
Thank you for being so open and sharing the lessons learned and how this process actually looks like.
not just for the strategy, but the reality of it.
It's been a real pressure.
And for our audience, thank you for tuning in to Global Trial Accelerators.
Showing 161–180 of 183 · page 9 of 10
← Previous
Next →